Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 6,352,717 protect, and when does it expire?

Patent ► Subscribe protects FORTOVASE and is included in one NDA.

Protection for FORTOVASE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has thirty-seven patent family members in thirty-four countries.

Summary for Patent: ► Subscribe

Title:	Process for encapsulating shear sensitive fill masses into capsules and capsules containing shear sensitive fill masses
Abstract:	The present invention provides a process for encapsulating a shear sensitive fill mass which contains a pharmaceutical active agent or nutrient, characterized in that said fill mass is heated and subsequently cooled, prior to the encapsulation. The invention also provides capsules comprising shear sensitive fill material obtained by the said process which have a high and constant dissolution rate.
Inventor(s):	Alex; Rainer (Weil am Rhein, DE), Gerhards; Jurgen (Arlesheim, CH), Kraemer-Pittrof; Ingeborg (Rheinfelden, DE), Oeschger; Richard (Rheinsulz, CH), Rades; Thomas (Dunedin, NZ)
Assignee:	Hoffman-La Roche Inc. (Nutley, NJ)
Application Number:	09/440,731
Patent Claim Types: see list of patent claims	Dosage form; Process; Formulation;

Glossary

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Type	RLD	RS	Patent No.	Patent Expiration	Delist Req.
Hoffmann La Roche	FORTOVASE	saquinavir	CAPSULE;ORAL	020828-001	Nov 7, 1997	DISCN	Yes	No	► Subscribe	► Subscribe	Y

This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: ► Subscribe

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	98121831	Nov 17, 1998

International Patent Family for Patent: ► Subscribe

Country	Document Number	Estimated Expiration
Canada	2350943	► Subscribe
China	1326335	► Subscribe
China	1172649	► Subscribe
Colombia	5150161	► Subscribe
Czech Republic	20011644	► Subscribe

This preview shows a limited data set Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

DrugPatentWatch Database Preview